Search

Alex T. Devito

Examiner (ID: 13221, Phone: (571)270-7551 , Office: P/2855 )

Most Active Art Unit
2855
Art Unit(s)
2856, 2855
Total Applications
868
Issued Applications
597
Pending Applications
73
Abandoned Applications
223

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4745293 [patent_doc_number] => 20080089895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Use of T-cell immune response cDNA 7 (TIRC7) in angiogenic and anti-angiogenic therapy' [patent_app_type] => utility [patent_app_number] => 11/906867 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9545 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089895.pdf [firstpage_image] =>[orig_patent_app_number] => 11906867 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/906867
Use of T-cell immune response cDNA 7 (TIRC7) in angiogenic and anti-angiogenic therapy Oct 3, 2007 Abandoned
Array ( [id] => 23893 [patent_doc_number] => 07795234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Newly identified human small intestine extracellular lactase-phlorizin hydrolase (ecLPH) gene' [patent_app_type] => utility [patent_app_number] => 11/901989 [patent_app_country] => US [patent_app_date] => 2007-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 20 [patent_no_of_words] => 6372 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795234.pdf [firstpage_image] =>[orig_patent_app_number] => 11901989 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/901989
Newly identified human small intestine extracellular lactase-phlorizin hydrolase (ecLPH) gene Sep 19, 2007 Issued
Array ( [id] => 4785485 [patent_doc_number] => 20080138814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'Compositions and Methods for Modulation of KSR1 and KSR2 Interactions' [patent_app_type] => utility [patent_app_number] => 11/833029 [patent_app_country] => US [patent_app_date] => 2007-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 11318 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138814.pdf [firstpage_image] =>[orig_patent_app_number] => 11833029 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/833029
Compositions and methods for modulation of KSR1 and KSR2 interactions Aug 1, 2007 Issued
Array ( [id] => 4740563 [patent_doc_number] => 20080234216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'TGF-beta type receptor cDNAs encoded products and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/880894 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9711 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234216.pdf [firstpage_image] =>[orig_patent_app_number] => 11880894 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/880894
TGF-beta type receptor cDNAs encoded products and uses therefor Jul 23, 2007 Abandoned
Array ( [id] => 4727999 [patent_doc_number] => 20080207543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'MODIFIED PITUITARY GLAND DEVELOPMENT IN OFFSPRING FROM EXPECTANT MOTHER ANIMALS TREATED WITH GROWTH HORMONE RELEASING HORMONE THERAPY' [patent_app_type] => utility [patent_app_number] => 11/774954 [patent_app_country] => US [patent_app_date] => 2007-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18874 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207543.pdf [firstpage_image] =>[orig_patent_app_number] => 11774954 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/774954
MODIFIED PITUITARY GLAND DEVELOPMENT IN OFFSPRING FROM EXPECTANT MOTHER ANIMALS TREATED WITH GROWTH HORMONE RELEASING HORMONE THERAPY Jul 8, 2007 Abandoned
Array ( [id] => 4664095 [patent_doc_number] => 20080255002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Genetic manipulation method' [patent_app_type] => utility [patent_app_number] => 11/809578 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22003 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255002.pdf [firstpage_image] =>[orig_patent_app_number] => 11809578 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/809578
Genetic manipulation method May 30, 2007 Abandoned
Array ( [id] => 5027965 [patent_doc_number] => 20070269412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'PLURIPOTENT CELLS' [patent_app_type] => utility [patent_app_number] => 11/755224 [patent_app_country] => US [patent_app_date] => 2007-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10394 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269412.pdf [firstpage_image] =>[orig_patent_app_number] => 11755224 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/755224
PLURIPOTENT CELLS May 29, 2007 Abandoned
Array ( [id] => 4976846 [patent_doc_number] => 20070218077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response' [patent_app_type] => utility [patent_app_number] => 11/749509 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23072 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218077.pdf [firstpage_image] =>[orig_patent_app_number] => 11749509 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/749509
Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response May 15, 2007 Abandoned
Array ( [id] => 4839436 [patent_doc_number] => 20080279921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Gel-formulations of hydrophobic photosensitizers for mucosal applications' [patent_app_type] => utility [patent_app_number] => 11/800599 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2366 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279921.pdf [firstpage_image] =>[orig_patent_app_number] => 11800599 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/800599
Gel-formulations of hydrophobic photosensitizers for mucosal applications May 6, 2007 Abandoned
Array ( [id] => 4959744 [patent_doc_number] => 20080274169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Photosensitizer formulations for topical applications' [patent_app_type] => utility [patent_app_number] => 11/800147 [patent_app_country] => US [patent_app_date] => 2007-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3171 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274169.pdf [firstpage_image] =>[orig_patent_app_number] => 11800147 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/800147
Photosensitizer formulations for topical applications May 3, 2007 Abandoned
Array ( [id] => 5091665 [patent_doc_number] => 20070231304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'PROGNOSTIC FACTORS FOR ANTI-HYPERPROLIFERATIVE DISEASE GENE THERAPY' [patent_app_type] => utility [patent_app_number] => 11/668981 [patent_app_country] => US [patent_app_date] => 2007-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 44909 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231304.pdf [firstpage_image] =>[orig_patent_app_number] => 11668981 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/668981
PROGNOSTIC FACTORS FOR ANTI-HYPERPROLIFERATIVE DISEASE GENE THERAPY Jan 29, 2007 Abandoned
Array ( [id] => 5259642 [patent_doc_number] => 20070213274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Novel genes and markers associated with high-density lipoprotein-cholesterol (HDL-C)' [patent_app_type] => utility [patent_app_number] => 11/640897 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84858 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213274.pdf [firstpage_image] =>[orig_patent_app_number] => 11640897 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/640897
Novel genes and markers associated with high-density lipoprotein-cholesterol (HDL-C) Dec 18, 2006 Abandoned
Array ( [id] => 5070195 [patent_doc_number] => 20070191297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'METHODS OF TREATING AND MONITORING SYSTEMIC LUPUS ERYTHEMATOSUS IN INDIVIDUALS' [patent_app_type] => utility [patent_app_number] => 11/565467 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 26066 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191297.pdf [firstpage_image] =>[orig_patent_app_number] => 11565467 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/565467
METHODS OF TREATING AND MONITORING SYSTEMIC LUPUS ERYTHEMATOSUS IN INDIVIDUALS Nov 29, 2006 Abandoned
Array ( [id] => 5095073 [patent_doc_number] => 20070116682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/604909 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16798 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20070116682.pdf [firstpage_image] =>[orig_patent_app_number] => 11604909 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/604909
Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof Nov 27, 2006 Abandoned
Array ( [id] => 5095075 [patent_doc_number] => 20070116684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/604918 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16792 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20070116684.pdf [firstpage_image] =>[orig_patent_app_number] => 11604918 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/604918
Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof Nov 27, 2006 Abandoned
Array ( [id] => 4825815 [patent_doc_number] => 20080124802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Method for labeling specific cells within living cells or tissues' [patent_app_type] => utility [patent_app_number] => 11/598690 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5313 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124802.pdf [firstpage_image] =>[orig_patent_app_number] => 11598690 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/598690
Method for labeling specific cells within living cells or tissues Nov 13, 2006 Abandoned
Array ( [id] => 4895622 [patent_doc_number] => 20080104722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'DISEASE MODEL ANIMALS OF METABOLIC SYNDROME AND A METHOD OF SCREENING PREVENTIVE AND THERAPEUTIC AGENTS FOR METABOLIC SYNDROME USING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/553125 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7867 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20080104722.pdf [firstpage_image] =>[orig_patent_app_number] => 11553125 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/553125
DISEASE MODEL ANIMALS OF METABOLIC SYNDROME AND A METHOD OF SCREENING PREVENTIVE AND THERAPEUTIC AGENTS FOR METABOLIC SYNDROME USING THE SAME Oct 25, 2006 Abandoned
Array ( [id] => 5125840 [patent_doc_number] => 20070238111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability' [patent_app_type] => utility [patent_app_number] => 11/584580 [patent_app_country] => US [patent_app_date] => 2006-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 8781 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238111.pdf [firstpage_image] =>[orig_patent_app_number] => 11584580 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/584580
Identification of genes or polypeptides the expression of which correlates to fertility, ovarian function and/or fetal/newborn viability Oct 22, 2006 Issued
Array ( [id] => 5080772 [patent_doc_number] => 20070123996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Stem cell comprising tissue substitutes' [patent_app_type] => utility [patent_app_number] => 11/582057 [patent_app_country] => US [patent_app_date] => 2006-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23466 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123996.pdf [firstpage_image] =>[orig_patent_app_number] => 11582057 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/582057
Tissue substitutes comprising stem cells and reduced ceria Oct 15, 2006 Issued
Array ( [id] => 4982425 [patent_doc_number] => 20070086983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Endothelium-targeting nanoparticle for reversing endothelial dysfunction' [patent_app_type] => utility [patent_app_number] => 11/545370 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12652 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20070086983.pdf [firstpage_image] =>[orig_patent_app_number] => 11545370 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/545370
Endothelium-targeting nanoparticle for reversing endothelial dysfunction Oct 9, 2006 Abandoned
Menu